Regular use of aspirin may cut the risk of pancreatic cancer in people with diabetes by 40%, a study has found. It may also ...

Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...

Learn about the hidden potential of aspirin. Discover 22 surprising ways to use aspirin in your everyday life.

The US FDA has approved a new drug, Cobenfy, for treating schizophrenia in adults. This is a first new class for medication ...

1 COBENFY represents the first new class of medicine in several decades and introduces a fundamentally new approach to treating schizophrenia by selectively targeting M 1 and M 4 receptors in the ...

To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video A child was caught trying to sell drugs to his own ...

The drug was developed by Karuna Therapeutics, which was bought by Bristol Myers Squibb (BMS) last year for $14 billion. This is the first new class of treatment for the psychiatric disorder since ...

But the simple virtue of being the first in a novel drug class can’t be overstated. The drug may be able to help people who haven’t responded to current therapies, and it’s likely to pave ...

There’s encouraging news for people with heart conditions, particularly those dealing with coronary artery disease—a ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett The Food and Drug Administration on ...

which classifies drugs into three categories, class A, B, and C, based on their perceived harm. While pink cocaine itself may not be explicitly listed, the substances commonly found in it are ...